Close

Logistics4Pharma completes GDP certification, ISO 9001:2015 certification and gains Authorised Economic Operator (AEO) status at Frankfurt Facility

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...
- Advertisement -

Logistics4Pharma, a pharmaceutical logistics and cold chain specialist, has recently completed GDP certification and ISO 9001:2015 quality management certifications for its Frankfurt, Germany cold chain storage and logistics facility. It also achieved the status of Authorised Economic Operator (AEO) which certifies the facility operates at the highest level of security and provide customers with the benefits of customs simplification procedures.

These advances follow a recent completion of a successful inspection from German Authorities validating compliance with good distribution practice (GDP) regulations for the storage and transportation of active pharmaceutical ingredients (APIs) and finished drug products. Logistics4Pharma has also passed a recent audit from the Luftfahrt-Bundesamt (LBA) renewing Regulated Agent status under the supervision of the German Aviation Administration.

“Throughout the COVID-19 pandemic, we have seen deep impacts across the supply chain which have been further exacerbated by global storage and transportation challenges,” said Kees Schmidt, Head of Operations at Logistics4Pharma. “While our team was already working to high standards and expanding its services pre-pandemic, these trends amplified the urgency of our efforts. We will continue to strengthen our compliance and commercial solutions to deliver deeper value to our European customers looking for a reliable cold-chain packaging, storage, and logistics partner in Frankfurt and around the world.”

Logistics4Pharma offers solutions tailored to meet individual customer needs, with a range for warehousing options (-15 to -25 DegC, 2 to 8 Deg C and 15 to 25 DegC), passive and active packaging solutions, transportation by air, land and sea, documentation, and customs clearance for active pharmaceutical ingredients (APIs), dangerous goods, and finished drug products. There are further plans to enhance the offer at the Frankfurt facility and include ultra-deep freeze capacity (-80 DegC) in the coming 12 months.

The company will be onsite in booth 18H12 at CPhI Worldwide from 9 to 11 November in Milan, Italy.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Global data analytics provider Axtria Inc. announced plans on...

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Following months of negotiations with industry stakeholders, the US...

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

CSPC Pharmaceutical and AstraZeneca have signed a joint venture...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »